A doctor in Manchester has secured £153,000 in funding after developing a mobile check-in system for hospitals.
MedCircuit allows patients to check into accident and emergency (A&E) departments using an iPad by answering questions about their condition.
It has been designed to speed up consultations by providing clinicians with medical information ahead of a patient’s assessment, cutting the amount of time spent taking notes and helping move patients through A&E more quickly.
The software is named after a company founded by former A&E doctor specialist, Lanre Olaitan.
Olaitan explained that A&E departments had not changed much in 70 years, with more patients waiting longer hours to be seen by doctors who had little information about them. “The demand for the MedCircuit software has been huge and the hospitals recognise the benefit it will have on their efficiency and in turn, on quality and patient satisfaction,” he said.
The £153,000 funding has been delivered by Mercia Equity Finance, which is managed by Mercia Fund Managers and part of the Northern Powerhouse Investment Fund (NPIF).
The cash will be used to further develop MedCircuit’s software and support trials in UK hospitals. Olaitan said the company was looking to secure partnerships with “numerous” hospitals in the North.
“The investment from Mercia will help MedCircuit complete and accelerate its pilots with several hospitals and NHS trusts around the UK, and adapt the software to other departments and areas in the hospital that also suffer from long waiting times,” he added.
MedCircuit recently secured a £50,000 grant from Innovate UK and an £80,000 investment from the Oxford Innovation Opportunity Network.
Jonny Sharp, investment manager with Mercia Fund Managers, added: “As a former A&E doctor, Lanre fully understands the hospital environment and patients’ clinical needs. He spotted the potential to improve efficiency and allow patients to be referred more quickly to the right department.
“In just a short space of time and with limited resources, he has succeeded in delivering a fully functioning product ready for hospital trials. This funding round will allow Lanre to further develop the software and to demonstrate its effectiveness by piloting it in multiple trial locations.”